Sildenafil enhances the peripheral antinociceptive effect of ellagic acid in the rat formalin test

Indian Journal of Pharmacology

Volumn 46, Issue 4, 2014, Pages 404-408

  Mansouri, Mohammad ^a   Naghizadeh, Bahareh ^a   Ghorbanzadeh, Behnam ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ellagic acid; formalin; peripheral antinociception; sildenafil

Indexed keywords

CYCLIC GMP; ELLAGIC ACID; NITRIC OXIDE; SILDENAFIL; ANALGESIC AGENT; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONAMIDE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; FORMALIN TEST; INFLAMMATORY PAIN; INTRAPLANTAR DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; NUCLEOTIDE METABOLISM; PAIN THRESHOLD; RAT; ANIMAL; DRUG COMBINATION; PAIN; PAIN MEASUREMENT; WISTAR RAT;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ELLAGIC ACID; MALE; PAIN; PAIN MEASUREMENT; PIPERAZINES; PURINES; RATS, WISTAR; SULFONAMIDES;

EID: 84905566121     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.135952     Document Type: Article

References (22)

1. Mixcoatl-Zecuatl T, Aguirre-Bañuelos P, Granados-Soto V. Sildenafi l produces antinociception and increases morphine antinociception in the formalin test. Eur J Pharmacol 2000;400:81-7.
2. Ferreira SH, Nakamura M. I-Prostaglandin hyperalgesia, a cAMP/Ca2+dependent process. Prostaglandins 1979;18:179-90.
3. Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use. Pharmacol Rev 2006;58:488-520.
4. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996;78:257-61.
5. El Desoky ES, Fouad IA. Pharmacological evidence for the role of nitric oxide-CGMP in antinociception. J Appl Res 2005;5:451-9.
6. Clifford MN, Scalbert A. Ellagitannins-Nature, occurrence and dietary burden. J Sci Food Agric 2000;80:1118-25.
7. Buniatian GH. Stages of activation of hepatic stellate cells: Effects of ellagic acid, an inhibitor of liver fi brosis, on their differentiation in culture. Cell Prolif 2003;36:307-19.
8. Festa F, Aglitti T, Duranti G, Ricordy R, Perticone P, Cozzi R. Antioxidant activity of ellagic acid in vitro revealed by the comet assay. Anticancer Res 2001;21:3903-8.
9. Liua QS, Panga ZR, Liub R, Heb GR, Cui J, Yinc X. Effective compounds group of Mongolian prescriptions BAIMAI-SAN protect against peripheral neuropathy in lower limbs of rats through neuroprotective effect. J Ethnopharmacol 2011;135:786-91.
10. Karlsson S, Nanberg E, Fjaeraa C, Wijkander J. Ellagic acid inhibits lipopolysaccharide-induced expression of enzymes involved in the synthesis of prostaglandin E2 in human monocytes. Br J Nutr 2010;103:1102-9.
11. Nascimento MV, Galdino PM, Florentino IF, Sampaio BL, Vanderlinde FA, de Paula JR, Costa EA. Antinociceptive effect of Lafoensia pacari A. St.-Hil. independent of anti-infl ammatory activity of ellagic acid. J Nat Med 2011;65:448-54.
12. Corbett S, Daniel J, Drayton R, Field M, Steinhardt R, Garrett N. Evaluation of the anti-inflammatory effects of ellagic acid. J Perianesth Nurs 2010;125:214-20.
13. Taghi Mansouri M, Naghizadeh B, Ghorbanzadeh B, Farbood Y. Central and peripheral antinociceptive effects of ellagic acid in different animal models of pain. Eur J Pharmacol 2013;707:46-53.
14. Dubuisson D, Dennis SG. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977;4:161-74.
15. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-10.
16. Ortiz MI, Granados-Soto V, Castañeda-Hernández G. The NO-cGMP-K+channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin. Pharmacol Biochem Behav 2003;76:187-95.
17. Puig S, Sorkin LS. Formalin-evoked activity in identifi ed primary afferent fi bers: Systemic lidocaine suppresses phase-2 activity. Pain 1996;64:345-55.
18. Durate ID, Lorenzetti BB, Ferreira SH. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur J Pharmacol 1990;186:289-93.
19. Soares AC, Duarte ID. Dibutyryl-cyclic GMP induces peripheral antinociception via activation of ATP-sensitive K+channels in the rat PGE2-induced hyperalgesic paw. Br J Pharmacol 2001;134:127-31.
20. Rivot JP, Montagne-Clavel J, Besson JM. Subcutaneous formalin and intraplantar carrageenan increase nitric oxide release as measured by in vivo voltammetry in the spinal cord. Eur J Pain 2002;6:25-34.
21. Rogerio AP, Fontanari C, Melo CM, Ambrosio SR, de Souza GE, Pereira PS, et al. Anti-infl ammatory, analgesic and anti-oedematous effects of Lafoensia pacari extract and ellagic acid. J Pharm Pharmacol 2006;58:1265-73.
22. Mansouri MT, Naghizadeh B, Ghorbanzadeh B. Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of ellagic acid in the rat formalin test. Pharmacol Biochem Behav 2014;120:43-9.